- Home
- SVRA vs ANSC Comparison
SVRA vs ANSC Comparison
Compare SVRA & ANSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- ANSC
- Stock Information
- Founded
- SVRA N/A
- ANSC 2021
- Country
- SVRA United States
- ANSC United States
- Employees
- SVRA N/A
- ANSC N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- ANSC
- Sector
- SVRA Health Care
- ANSC
- Exchange
- SVRA Nasdaq
- ANSC Nasdaq
- Market Cap
- SVRA 458.2M
- ANSC 453.9M
- IPO Year
- SVRA N/A
- ANSC 2023
- Fundamental
- Price
- SVRA $2.69
- ANSC $10.56
- Analyst Decision
- SVRA Buy
- ANSC
- Analyst Count
- SVRA 7
- ANSC 0
- Target Price
- SVRA $9.86
- ANSC N/A
- AVG Volume (30 Days)
- SVRA 633.7K
- ANSC 26.7K
- Earning Date
- SVRA 03-06-2025
- ANSC 01-01-0001
- Dividend Yield
- SVRA N/A
- ANSC N/A
- EPS Growth
- SVRA N/A
- ANSC N/A
- EPS
- SVRA N/A
- ANSC 0.21
- Revenue
- SVRA N/A
- ANSC N/A
- Revenue This Year
- SVRA N/A
- ANSC N/A
- Revenue Next Year
- SVRA N/A
- ANSC N/A
- P/E Ratio
- SVRA N/A
- ANSC $50.49
- Revenue Growth
- SVRA N/A
- ANSC N/A
- 52 Week Low
- SVRA $2.59
- ANSC $10.12
- 52 Week High
- SVRA $5.70
- ANSC $10.60
- Technical
- Relative Strength Index (RSI)
- SVRA 40.81
- ANSC 62.76
- Support Level
- SVRA $2.65
- ANSC $10.54
- Resistance Level
- SVRA $2.91
- ANSC $10.54
- Average True Range (ATR)
- SVRA 0.11
- ANSC 0.01
- MACD
- SVRA 0.01
- ANSC 0.00
- Stochastic Oscillator
- SVRA 23.08
- ANSC 50.00
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About ANSC Agriculture & Natural Solutions Acquisition Corporation
Agriculture & Natural Solutions Acquisition Corp is a blank check company.